Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects

Inclusion Criteria: * Healthy male subjects (ages 18 to 45) as determined by medical history, physical examination, 12-lead electrocardiogram (ECG), and clinical laboratory evaluations will be eligible to participate in the study Exclusion Criteria: * Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG or clinical laboratory determinations * Participation in a radiolabeled investigational study drug trial within 12 months prior to admission to the clinical facility * Exposure to significant radiation within 12 months prior to admission to the clinical facility